Vancouver, Washington. xChemistry DNA, LLC has launched its website, cannaGx.com, making its revolutionary DNA test available to those wanting have their personal genome analyzed. This comprehensive analysis identifies how an individual metabolizes, processes, and responds to cannabinoids (cannabis) and how it may provide relief from ailments including pain, insomnia, and anxiety.
“Two years of research by our team of scientists and technicians, has resulted in confidently making our DNA test available to the general public. The key is being able to genetically unlock an individual’s risks in the use of opioids and other prescription medications and how certain strains and doses of cannabinoids will replace those potentially dangerous treatments,” notes Chuck Nokes, xChemistry DNA’s President.
Every CannaGx DNA Test report summarizes a person’s genetic profile and recommends certain methods of utilizing cannabis for its most powerful impact on one’s health and wellbeing. Included in each report is a thorough, technical explanation of its findings as well as a list of potential side effects. Mr. Nokes also makes it very clear that xChemistry DNA is the only laboratory testing multiple pathways in the ECS (ENDOCANNABINOID SYSTEM), not solely the metabolism of cannabis products. This is one giant leap in the direction of empowering people to take control of their health through personalized testing.
xChemistry DNA’s research and testing provide the most ethical, reliable, and irrefutable science available to support the ever-growing passion of people to improve their health and enhance their lifestyle experience.
Media Interviews Available
Charles J. Sailey, MD, MS, FCAP, FASCP